Sam's News — health — 2026-08-07¶
TL;DR¶
- Replimune FDA approval of melanoma drug succeeds after previous rejections
- Scientists discover hidden brain shift beginning around age 50 linked to Alzheimer's disease
- Blocking glycine transporter SLC6A20 reverses autism symptoms in adult mice
- Wearable ultrasound patch accelerates REM sleep onset by 43 minutes without drugs or surgery
- Antarctic isolation study finds crew tension increases with excessive social contact, shaping Mars mission planning
Health¶
Replimune FDA approval of melanoma drug succeeds after previous rejections¶
The FDA approved Replimune's melanoma treatment after the company's two prior rejection applications, marking a major biotech win.
Sources: STAT News RSS
Scientists discover hidden brain shift beginning around age 50 linked to Alzheimer's disease¶
Research shows that around age 50, the brain's memory center loses longtime immune cells and replaces them with inflammatory ones, potentially explaining Alzheimer's onset.
Sources: ScienceDaily RSS, ScienceDaily — Health RSS
Blocking glycine transporter SLC6A20 reverses autism symptoms in adult mice¶
Blocking the glycine transporter SLC6A20 restored brain signaling and improved social, communication, and repetitive behaviors in autism-related mouse models and human organoids.
Sources: ScienceDaily RSS, ScienceDaily — Health RSS
Wearable ultrasound patch accelerates REM sleep onset by 43 minutes without drugs or surgery¶
A wearable ultrasound patch shortened REM sleep onset by 43 minutes and extended it by 16 minutes, improving stress regulation without medication.
Sources: ScienceDaily RSS, ScienceDaily — Health RSS
Science¶
Antarctic isolation study finds crew tension increases with excessive social contact, shaping Mars mission planning¶
A ten-month Antarctic study showed astronauts may struggle more with frequent contact than loneliness, informing future Mars mission crew composition.
Sources: ScienceDaily RSS, ScienceDaily — Health RSS